OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,490,816 | +17.1% | 6,117,400 | 0.0% | 0.79% | +61.0% |
| Q2 2023 | $20,065,072 | +27.1% | 6,117,400 | 0.0% | 0.49% | -3.1% |
| Q1 2023 | $15,782,892 | +38.7% | 6,117,400 | 0.0% | 0.51% | +46.8% |
| Q4 2022 | $11,378,364 | +1.1% | 6,117,400 | 0.0% | 0.35% | +4.2% |
| Q3 2022 | $11,256,000 | -14.4% | 6,117,400 | 0.0% | 0.33% | -26.9% |
| Q2 2022 | $13,152,000 | -31.5% | 6,117,400 | 0.0% | 0.45% | -24.5% |
| Q1 2022 | $19,209,000 | -1.6% | 6,117,400 | +0.6% | 0.60% | -3.4% |
| Q4 2021 | $19,524,000 | -4.5% | 6,082,200 | 0.0% | 0.62% | -12.5% |
| Q3 2021 | $20,436,000 | -14.1% | 6,082,200 | 0.0% | 0.71% | -20.0% |
| Q2 2021 | $23,781,000 | -2.7% | 6,082,200 | 0.0% | 0.89% | -18.0% |
| Q1 2021 | $24,450,000 | – | 6,082,200 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
| BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
| EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
| GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
| Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
| CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
| Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
| DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
| Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
| XTX Topco Ltd | 50,569 | $198,000 | 0.07% |